Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INNV · against 588 other Healthcare companies listed in US-listed
Ranked #245 of 589 · scores higher than 58% of peers
Bars: peers in each 10-point band of the valuation score75 peers with a valuation score of 30–39, including INNV · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | INNV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -0.2% | -4.3% | 63% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 2.3% | -0.8% | 58% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 4.2% | -2.3% | 79% | 20% | |
| Book yieldHigher is better · 587 reported | 19.6% | 25.9% | 41% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 239 | 9.1B USD | 38 | 74 | |
| 239 | 45.2B USD | 38 | 46 | |
| 245 | 5.2B USD | 37 | 74 | |
| 245 | 8.6B USD | 37 | 30 | |
| 245 | 1.2B USD | 37 | 49 | |
| 245 | 10.1B USD | 37 | 61 | |
| 245 | 2.7B USD | 37 | 44 | |
| 250 | 16.5B USD | 36 | 37 | |
| 250 | 1.2B USD | 36 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score